Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03105362 · ClinicalTrials.gov registry record · NA
Amino Acid-based Oral Rehydration Solution in Children With Short Bowel Syndrome
A NA study, sponsored by Boston Children's Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT03105362 is a NA study that was terminated before completion, run by Boston Children's Hospital. The registered enrollment target is 4 participants.
The verdict
NCT03105362, a NA study, was terminated before completion, sponsored by Boston Children's Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
This study will assess the tolerability and palatability of an amino acid based oral rehydration solution (enterade®) compared to current oral rehydration solution among children with short bowel syndrome .
Interventions
- DIETARY_SUPPLEMENT Enterade® oral rehydration solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2017-08-16 |
| Est. Completion | 2018-04-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03105362
The ClinicalTrials.gov registry entry for NCT03105362 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Enterade® oral rehydration solution is the first listed.
NCT03105362 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03105362 about?
NCT03105362 is a clinical study titled "Amino Acid-based Oral Rehydration Solution in Children With Short Bowel Syndrome". This study will assess the tolerability and palatability of an amino acid based oral rehydration solution (enterade®) compared to current oral rehydration solution among children with short bowel syndrome .
What is the current status of trial NCT03105362?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2017-08-16. Estimated completion is 2018-04-03.
What interventions are being tested in trial NCT03105362?
The interventions under investigation include: Enterade® oral rehydration solution (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03105362?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.